Question 1

Who are the latest insiders trading Gain Therapeutics, Inc. (GANX) stock?

Accepted Answer

The most recent insider trade for Gain Therapeutics, Inc. (GANX) was by Islam Khalid on June 24, 2025, who executed a purchase of 15,000 shares at $1.79 per share.

Question 2

How much GANX stock was sold by insiders this month?

Accepted Answer

There have been no insider sales recorded for Gain Therapeutics, Inc. (GANX) in the past 30 days. This could suggest insiders are holding their positions.

Question 3

Does Gain Therapeutics, Inc. show consistent insider selling or buying?

Accepted Answer

Over the last 12 months, insider activity at Gain Therapeutics, Inc. (GANX) shows a general trend of buying, with 0 sale transactions and 7 purchase transactions recorded.

Question 4

Are executives at Gain Therapeutics, Inc. actively trading their shares?

Accepted Answer

Yes, recent executive trades have been recorded. For example, Islam Khalid reported a purchase of 15,000 shares on 6/24/2025.

Gain Therapeutics, Inc.